Work

Treatment satisfaction with ITCA 650, a novel drug‐device delivering continuous exenatide, versus twice‐daily injections of exenatide in type 2 diabetics using metformin

Year: 2017

Type: article

Study design: Clinical Trial

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.13133

Authors: Robert Henry, Julio Rosenstock, John F. McCarthy, Ginger Carls, Tom Alessi, John Yee, Michelle Baron

Institutions: University of California San Diego, Dallas Diabetes Research Center, Intarcia Therapeutics (United States), Analysis Group (United States)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Intarcia Therapeutics

OpenAlex ID: W2766655935

FWCI: 0.648

Cites: 45

Cited by: 7

Related to: 10